Pliant Therapeutics PLRX
NASDAQ PLRX
$1.05 -0.03 (-2.78%)
At close: Oct 1, 2026 · 4:00 PM EDT

Pliant Therapeutics (PLRX) Non Operating Interest Expenses (2022 - 2025)

Updated

Pliant Therapeutics' Non Operating Interest Expenses was $136,000 in Q4 2025, down 83.7% from $834,000 a year earlier and down 83.3% from the prior quarter.

Analysis

Pliant Therapeutics (PLRX) Non Operating Interest Expenses (2022 - 2025) Analysis & Trends

For FY2025, Non Operating Interest Expenses at Pliant Therapeutics came in at $2.56 million, down 15.4% from FY2024.

  • Non Operating Interest Expenses shows a three-year compound annual growth rate of 47.9% (FY2022 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $3.02 million in FY2024 (+138.7%), $1.27 million in FY2023 (+60.2%) and $791,000 in FY2022.
  • The Q4 2025 figure marks the lowest quarterly Non Operating Interest Expenses in data going back to Q2 2022.
  • Compared with a year earlier, Non Operating Interest Expenses has declined for three straight quarters, with growth averaging 66.7% over the last eight quarters.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q3 2024 (growth of 176.7%); the worst was Q4 2025 (a decline of 83.7%).
  • Per Business Quant data, PLRX's Non Operating Interest Expenses in the three quarters before Q4 2025 was $815,000 (Q3 2025), $809,000 (Q2 2025) and $799,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Pliant Therapeutics 66.87 Mn 66.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 136,000.00
Sep 30, 2025 815,000.00
Jun 30, 2025 809,000.00
Mar 31, 2025 799,000.00
Dec 31, 2024 834,000.00
Sep 30, 2024 877,000.00
Jun 30, 2024 868,000.00
Mar 31, 2024 445,000.00
Dec 31, 2023 321,000.00
Sep 30, 2023 317,000.00
Jun 30, 2023 319,000.00
Mar 31, 2023 311,000.00
Dec 31, 2022 317,000.00
Sep 30, 2022 301,000.00
Jun 30, 2022 173,000.00
API Access

Pliant Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=PLRX&period=max&api_key=YOUR_API_KEY